Medtech clinical trials navigate macro trends and regulatory changes
An upcoming conference will investigate the latest trends in the medical devices and medtech clinical trials industry with a focus…
All articles by Manasi Vaidya
Manasi Vaidya
@manasivaidya22
Manasi Vaidya is an editor for GlobalData Insights where she covers the healthcare space. She writes and edits features that look at the research, regulation and reimbursement of drugs with a focus on topics at the intersection of business and science.
-
-
Trump picks vaccine sceptic RFK Jr to lead HHS in new administration
President-elect Donald Trump has appointed Robert F Kennedy Jr, popularly known as RFK Jr, as the secretary of the premier…
-
How to connect patients with rare diseases to clinical trials
Rare disease clinical research is no longer an afterthought for pharmaceutical companies with rapid approvals and increased investment in this…
-
Rare disease drug development needs regulatory incentives to grow in 2024
Last year, over half of the novel drugs approved by the US Food and Drug Administration (FDA) were orphan drugs,…
-
Looking back at 2022: The top healthcare stories
The healthcare industry saw its share of ups and downs in 2022. Our response to the worldwide pandemic evolved over…
-
Why aren’t digital pills taking off?
In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor…